DISCOVERY, DEVELOPMENT, DEPLOYMENTFOR GLOBAL HEALTH, with SCIENCE & BUSINESS ACUMEN


MISSION

We are a professional firm that can DISCOVER technological seeds and ideas, DEVELOP them into viable products and services, and DEPLOY to the society to improve global health partnering with established corporations who share our passion

BUSINESS

INVESTMENTS

D3 Bio Healthcare Fund
Venture Capital (LPS in Japan)
FOCUS: Early Stage biotech and digital healthcare start-ups with tech and idea potentially contribute to global health issues

CONSULTING

Management advisory
Growth Strategy (Corporate, Business)
New Business Development
Innovation

Investment advisory
Private Equity (buyout)
Growth Capital

#PARTNERS

TOMOYA NAGATA, M.S. R.Ph.
Managing Partner, CEO

FIL Capital Management (HK) Ltd. | McKinsey (Strategy & Innovation) | M.S. and B.S. in Pharma. Sci., Univ. of Tokyo | UC Berkley HaaS VCEP | Registered Pharmacist

KENJI WATATANI, Ph.D.
Partner, COO

McKinsey (Pharmaceuticals & Medical Products) | PD in Kyoto Univ. (iCeMS)| Ph.D. in Mol. Biol., Univ. of Tokyo

#VENTURE PARTNERS

YUJI SUZUKI, M. Phil.
Venture Partner (China)

Human Metabolome Technologies (Exec. Officer) | Macromill (Global Strategy) | McKinsey (Greater China, Japan) | Financial Services Agency | Ministry of Foreign Affairs | M.Phil., Univ. of Cambridge | B.A., Univ. of Tokyo

YASUAKI HASEBE, M.D.
Venture Partner

Activaid (Founder CEO) | Novartis (Basel, Tokyo) | McKinsey | M.D., Nagoya Univ.

And more.

CONTACT

info@d3growth.com